NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024

Offer reference number: CM/PHS/22/5561

Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Additional information:

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: …@atamis.co.uk

Tender Documents

• Opportunity notice on Contracts Finder → — Tender notice
• Document No. 02 - Terms of offer CM-PHS-22-5561 →
• Document No. 04e - Management information schedule →
• Document No. 05a - Offer Schedule CM-PHS-22-5561 →
• Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS CM-PHS-22-5561 →
• Document No. 07a - Quality control technical sheet CM-PHS-22-5561 →
• Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHS-22-5561 →
• Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM-PHS-22-5561 →
• Document No. 09 - Participating Authorities CM-PHS-22-5561 →
• Document No. 06 - Form of offer CM-PHS-22-5561 →
• Document No. 05 - Contract technical specification CM-PHS-22-5561 →
• Document No. 04d - Supplier Management Information Schedule →
• Document No. 05b - Scoring Methodology and Award Criteria CM-PHS-22-5561 →
• Document No. 01 - Invitation to offer covering letter CM-PHS-22-5561 →
• Document No. 04a - Quality Assurance Process →